Gain Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.55 | $56.28 M | -5.86 | 2 | $0 |
 BIVI
|
BioVie Inc. | $3.16 | $26.30 M | -0.46 | 14 | $0 |
 CELC
|
Celcuity Inc. | $14.07 | $501.59 M | -5.14 | 55 | $0 |
 CSBR
|
Champions Oncology, Inc. | $4.46 | $62.53 M | -6.39 | 210 | $50.16 M |
 CUE
|
Cue Biopharma, Inc. | $1.51 | $71.99 M | -1.38 | 53 | $5.49 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 ELVN
|
Enliven Therapeutics, Inc. | $24.90 | $984.95 M | -11.97 | 46 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 INAB
|
IN8bio, Inc. | $0.34 | $59.13 M | -1.49 | 39 | $0 |
 INBX
|
Inhibrx Biosciences, Inc. | $14.39 | $241.02 M | -1.44 | 166 | $1.80 M |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 LTRN
|
Lantern Pharma Inc. | $3.49 | $60.03 M | -3.44 | 21 | $0 |
 MACK
|
Merrimack Pharmaceuticals, Inc. | $15.15 | $223.75 M | -168.11 | 0 | $0 |
 MNOV
|
MediciNova, Inc. | $1.84 | $67.19 M | -8.06 | 13 | $1.00 M |
 MOLN
|
Molecular Partners AG | $5.25 | $135.05 M | -2.03 | 167 | $7.04 M |
 NAMS
|
NewAmsterdam Pharma Company N.V. | $24.98 | $1.74 B | -7.15 | 62 | $12.76 M |
 TFFP
|
TFF Pharmaceuticals, Inc. | $1.62 | $5.45 M | -0.19 | 19 | $733,871 |